NON-TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA

Clinical trials for NON-TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA explained in plain language.

Never miss a new study

Get alerted when new NON-TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA trials appear

Sign up with your email to follow new studies for NON-TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New pill aims to boost energy for people with inherited blood disorder

Disease control Ongoing

This study tested whether an oral medication called mitapivat could improve anemia and reduce fatigue in adults with non-transfusion-dependent thalassemia, a genetic blood disorder. About 194 participants were randomly assigned to receive either mitapivat or a placebo pill for 24…

Matched conditions: NON-TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA

Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

NON-TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA

Get alerted when new NON-TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA trials appear

New pill aims to boost energy for people with inherited blood disorder